Our position on
Learn more about our views and our practices across a range of issues that are important to GSK, our patients and consumers, and our stakeholders.
Access to medicines and vaccines
- Patents and access to medicines in developing countriesPDF - 188.1KB
- Technology transfer, capacity building and developing countriesPDF - 232.7KB
- Tiered pricing and vaccinesPDF - 150.2KB
- Civil society organisations and vaccine procurementPDF - 152.3KB
- Tackling Global Health ChallengesPDF - 182.8KB
- Treatment Use of Unlicensed MedicinesPDF - 156.9KB
- Product donationsPDF - 151.7KB
Research & Development
- Our Approach to Clinical TrialsPDF - 152.2KB
- Cloning and Stem Cell TechnologiesPDF - 38.7KB
- The convention on biological diversityPDF - 239.9KB
- Public disclosure of clinical researchPDF - 175.1KB
- The care, welfare and treatment of animalsPDF - 42.2KB
- PharmacovigilancePDF - 147.8KB
- Falsified and Substandard Healthcare productsPDF - 165.6KB
Intellectual Property
- Incremental innovationPDF - 177.4KB
- Compulsory licensingPDF - 195.1KB
- EvergreeningPDF - 139.7KB
- A disclosure requirement in patent lawPDF - 196.4KB
- Regulatory data protectionPDF - 189.2KB
Health security
- Pandemic preparednessPDF - 270.4KB
- Combating antimicrobial resistancePDF - 151.0KB
Environment and nature impact
- Hazardous chemicals managementPDF - 178.2KB
- Genetically modified micro-organisms and Environment, Health and Safety (EHS)PDF - 187.4KB
- NanotechnologyPDF - 161.2KB
- Respiratory Products and Global WarmingPDF - 132.6KB
- Pharmaceuticals in the environmentPDF - 160.7KB
- The impact of climate change on healthPDF - 164.2KB
- Climate Change and GSK’s OperationsPDF - 152.0KB
- Water stewardshipPDF - 132.5KB
- Deforestation-free sourcingPDF - 156.0KB
- Environmental managementPDF - 129.9KB
Business integrity
- Engagement with patient organisationsPDF - 317.6KB
- Conflict mineralsPDF - 193.7KB
- Competitiveness and investment criteriaPDF - 182.4KB
- Human rightsPDF - 144.6KB
- Marketing practices and scientific engagementPDF - 155.8KB
- Safeguarding personal informationPDF - 196.3KB
- Tax strategyPDF - 298.1KB
- Political AdvocacyPDF - 168.4KB
- Working with third partiesPDF - 252.4KB
- Lethal InjectionsPDF - 79.0KB
